[go: up one dir, main page]

FI922958L - Farmaceutisk sammansaettning - Google Patents

Farmaceutisk sammansaettning Download PDF

Info

Publication number
FI922958L
FI922958L FI922958A FI922958A FI922958L FI 922958 L FI922958 L FI 922958L FI 922958 A FI922958 A FI 922958A FI 922958 A FI922958 A FI 922958A FI 922958 L FI922958 L FI 922958L
Authority
FI
Finland
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
FI922958A
Other languages
English (en)
Other versions
FI922958A0 (fi
FI109454B (fi
Inventor
Birgit Hauer
Armin Meinzer
Ulrich Posanski
Jacky Vonderscher
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10697415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI922958(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI922958A0 publication Critical patent/FI922958A0/fi
Publication of FI922958L publication Critical patent/FI922958L/fi
Priority to FI961513A priority Critical patent/FI116199B/fi
Application granted granted Critical
Publication of FI109454B publication Critical patent/FI109454B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
    • C11C3/04—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils
    • C11C3/06—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils with glycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nanotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Wood Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fats And Perfumes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Confectionery (AREA)
FI922958A 1991-06-27 1992-06-25 Menetelmä farmaseuttisen koostumuksen valmistamiseksi FI109454B (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI961513A FI116199B (fi) 1991-06-27 1996-04-03 Transesteröityjä maissiöljytuotteita ja niiden käyttö farmaseuttisessa koostumuksessa

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9113872 1991-06-27
GB919113872A GB9113872D0 (en) 1991-06-27 1991-06-27 Improvements in or relating to organic compounds

Publications (3)

Publication Number Publication Date
FI922958A0 FI922958A0 (fi) 1992-06-25
FI922958L true FI922958L (fi) 1992-12-28
FI109454B FI109454B (fi) 2002-08-15

Family

ID=10697415

Family Applications (2)

Application Number Title Priority Date Filing Date
FI922958A FI109454B (fi) 1991-06-27 1992-06-25 Menetelmä farmaseuttisen koostumuksen valmistamiseksi
FI961513A FI116199B (fi) 1991-06-27 1996-04-03 Transesteröityjä maissiöljytuotteita ja niiden käyttö farmaseuttisessa koostumuksessa

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI961513A FI116199B (fi) 1991-06-27 1996-04-03 Transesteröityjä maissiöljytuotteita ja niiden käyttö farmaseuttisessa koostumuksessa

Country Status (38)

Country Link
EP (2) EP0539319B1 (fi)
JP (2) JP2653958B2 (fi)
KR (3) KR0131064B1 (fi)
CN (1) CN1077798C (fi)
AT (1) AT403436B (fi)
AU (1) AU659460B2 (fi)
CA (2) CA2175842C (fi)
CH (2) CH685764A5 (fi)
CY (1) CY1906A (fi)
CZ (1) CZ281790B6 (fi)
DE (3) DE4219526C2 (fi)
DK (2) DK0953630T3 (fi)
EE (1) EE03108B1 (fi)
ES (2) ES2142818T3 (fi)
FI (2) FI109454B (fi)
FR (2) FR2678169B1 (fi)
GB (2) GB9113872D0 (fi)
GR (1) GR3032366T3 (fi)
HK (2) HK57196A (fi)
HU (1) HU216792B (fi)
IE (1) IE73662B1 (fi)
IL (3) IL118546A (fi)
IT (1) IT1254401B (fi)
LU (1) LU88138A1 (fi)
MX (1) MX9203236A (fi)
MY (1) MY109512A (fi)
NO (2) NO303964B1 (fi)
NZ (1) NZ243309A (fi)
PH (1) PH30337A (fi)
PT (2) PT953630E (fi)
RO (2) RO111021B1 (fi)
RU (1) RU2143919C1 (fi)
SA (1) SA92130213B1 (fi)
SK (1) SK278759B6 (fi)
TW (1) TW267943B (fi)
UA (1) UA35559C2 (fi)
UY (1) UY23864A1 (fi)
ZA (1) ZA924719B (fi)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
EP0589843B1 (en) * 1992-09-25 2001-11-28 Novartis AG Pharmaceutical compositions containing cyclosporins
NZ247516A (en) * 1993-04-28 1995-02-24 Bernard Charles Sherman Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant
CH686761A5 (de) * 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
AT408520B (de) * 1993-05-27 2001-12-27 Novartis Erfind Verwalt Gmbh Galenische formulierungen
GB2278780B (en) * 1993-05-27 1998-10-14 Sandoz Ltd Macrolide formulations
EP0649651B1 (en) 1993-09-28 2000-12-13 R.P. Scherer GmbH Soft gelatin capsule manufacture
DE4340781C3 (de) * 1993-11-30 2000-01-27 Novartis Ag Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
EP0694308A4 (en) * 1994-02-17 1997-09-10 Shiseido Co Ltd CYCLOSPORIN EMULSION COMPOSITION
US5891846A (en) * 1994-02-17 1999-04-06 Shiseido Company, Ltd. Cyclosporin-containing emulsion composition
NZ270145A (en) * 1994-03-01 1996-08-27 Lilly Co Eli Non-aqueous pharmaceutical formulation for oral administration comprising water-insoluble active agent, fatty acid solubilising agent, an oil and a surface active agent
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
EP0679712B1 (en) * 1994-03-31 1999-06-23 Loders Croklaan B.V. Low safa oils
GB2308545B (en) * 1994-10-26 1999-06-02 Novartis Ag Pharmaceutical microemulsion preconcentrates
IL129547A (en) 1994-10-26 2001-01-11 Novartis Ag Pharmaceutical compositions comprising a macrolide and an acid
DK0789580T3 (da) 1994-11-03 2002-09-09 Novartis Ag Nye præparatformer for cyclosporin til oral administration med simpel sammensætning og høj biotilgængelighed, og fremgangsmåder til deres fremstilling
HU215966B (hu) * 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
CA2220451A1 (en) * 1995-05-17 1996-11-21 Cedars-Sinai Medical Center Methods and compositions for improving digestion and absorption in the small intestine
WO1996036330A2 (en) * 1995-05-17 1996-11-21 Cedars-Sinai Medical Center Compositions containing fatty acids for improving digestion and absorption in the small intestine
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6008228A (en) * 1995-06-06 1999-12-28 Hoffman-La Roche Inc. Pharmaceutical compositions containing proteinase inhibitors
US6696413B2 (en) * 1995-06-16 2004-02-24 Hexal Ag Pharmaceutical preparation with cyclosporin A
SE504582C2 (sv) * 1995-07-06 1997-03-10 Gs Dev Ab Cyklosporinkomposition baserad på en L2-fas
DE19549852B4 (de) 1995-11-29 2009-06-04 Novartis Ag Cyclosporin enthaltende Präparate
US5858401A (en) 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
CN1104258C (zh) * 1996-05-29 2003-04-02 周德和 用于环孢霉素a的赋形剂
US5958876A (en) * 1996-06-19 1999-09-28 Novartis Ag Cyclosporin-containing pharmaceutical compositions
KR20040000379A (ko) * 1996-06-19 2004-01-03 노파르티스 아게 사이클로스포린-함유 연질캅셀제
KR980008239A (ko) * 1996-07-26 1998-04-30 김충환 사이클로스포린-함유 약학적 조성물
FR2752732B1 (fr) * 1996-08-28 1998-11-20 Pf Medicament Forme galenique a liberation prolongee de milnacipran
US6517860B1 (en) 1996-12-31 2003-02-11 Quadrant Holdings Cambridge, Ltd. Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery
WO1999027946A1 (en) * 1997-12-02 1999-06-10 Chong Kun Dang Corp. Pharmaceutical composition comprising cyclosporin solid-state microemulsion
DE69828496T2 (de) * 1997-03-12 2006-03-23 Abbott Laboratories, Abbott Park Hydrophile binäre systeme zur verabreichung von cyclosporin
NZ314702A (en) * 1997-04-29 1998-07-28 Bernard Charles Sherman Pharmaceutical composition comprising a cyclosporin in a solvent system of acetylated monoglycerides and a surfactant and optionally a hydrophilic solvent
AR012627A1 (es) 1997-04-29 2000-11-08 Sherman Bernard Charles Pre-concentrado de emulsion que comprende una ciclosporina y monoglicerido acetilado
GB2326337A (en) 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
HU228923B1 (en) 1997-07-29 2013-06-28 Upjohn Co Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation
ES2219895T3 (es) * 1997-07-29 2004-12-01 PHARMACIA & UPJOHN COMPANY Formulacion autoemulsionante para compuestos lipofilos.
KR100509130B1 (ko) * 1997-07-29 2005-08-18 파마시아 앤드 업존 캄파니 엘엘씨 친지성 화합물의 자가유화 제제
US20030220234A1 (en) 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
US6201165B1 (en) 1997-10-16 2001-03-13 Board Of Regents, University Of Texas System Transgenic animal models for cardiac hypertrophy and methods of use thereof
AU743098B2 (en) 1997-12-10 2002-01-17 Cyclosporine Therapeutics Limited Pharmaceutical compositions containing an omega-3 fatty acid oil
ID25908A (id) * 1998-03-06 2000-11-09 Novartis Ag Prakonsentrat-prakonsentrat emulsi yang mengandung siklosporin atau makrolida
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
EP0982035B1 (en) * 1998-08-18 2004-03-31 Panacea Biotec Limited Cyclosporin composition comprising an hydrophilic carrier
US7026290B1 (en) 1998-12-30 2006-04-11 Dexcel Ltd. Dispersible concentrate for the delivery of cyclosprin
GB9903547D0 (en) 1999-02-16 1999-04-07 Novartis Ag Organic compounds
CN1167462C (zh) * 1999-03-09 2004-09-22 杭州华东医药集团生物工程研究所有限公司 一种含环孢素的药物组合物
US6956048B2 (en) 1999-03-31 2005-10-18 Pharmacia & Upjohn Company Pharmaceutical emulsions for retroviral protease inhibitors
AU2127400A (en) * 1999-11-02 2001-05-14 Cipla Limited A pharmaceutical composition for the administration of water-insoluble pharmaceutically active substances and process for preparation thereof
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
GB0008785D0 (en) 2000-04-10 2000-05-31 Novartis Ag Organic compounds
EP1430783B1 (en) * 2000-08-08 2006-10-11 Kao Corporation Oil/fat composition
US7115565B2 (en) 2001-01-18 2006-10-03 Pharmacia & Upjohn Company Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
MXPA04003625A (es) 2001-10-19 2004-12-02 Sotechnika Inc Sintesis de analogos de ciclosporina.
MEP89008A (en) 2001-10-19 2011-12-20 Novel cyclosporin analog microemulsion preconcentrates
KR100441167B1 (ko) * 2001-12-27 2004-07-21 씨제이 주식회사 마이크로에멀젼 예비 농축액 조성물
KR100525234B1 (ko) * 2003-02-19 2005-10-28 한국유나이티드제약 주식회사 사이클로스포린 함유 연질캅셀제 및 그 제조방법
GT200500310A (es) 2004-11-19 2006-06-19 Compuestos organicos
GB0504950D0 (en) 2005-03-10 2005-04-20 Novartis Ag Organic compositions
JP4889262B2 (ja) * 2005-08-19 2012-03-07 理研ビタミン株式会社 脂溶性薬剤組成物
MD3347G2 (ro) * 2006-12-26 2008-01-31 Институт Сельскохозяйственной Техники "Mecagro" Procedeu de obţinere a esterilor metilici din ulei de rapiţă
ITPD20070049A1 (it) * 2007-02-14 2008-08-15 Sila S R L Prodotto a base di acido linoleico coniugato e processo per la sua fabbricazione
CA2683415C (en) 2007-04-04 2020-12-08 Sigmoid Pharma Limited An oral pharmaceutical composition
CN101199836B (zh) * 2007-11-07 2011-03-30 安徽省药物研究所 一种阶段释放型环孢素a固体微乳制剂及其微乳固化方法
EP2432455B1 (en) 2009-05-18 2014-11-12 Sigmoid Pharma Limited Composition comprising oil drops
BR112012002963A2 (pt) 2009-08-12 2017-10-24 Sigmoid Pharma Ltd composições imunomoduladoras compreendendo uma matriz de polímero e uma fase oleosa
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
JO3337B1 (ar) * 2010-12-13 2019-03-13 Debiopharm Sa تركيبات صيدلية تشمل أليسبوريفير
FR2971941B1 (fr) 2011-02-24 2013-08-02 Physica Pharma Compositions pharmaceutiques administrables par voie cutanee et destinees au traitement local de la dermatite atopique canine
GB201304662D0 (en) 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
EA036036B1 (ru) 2014-11-07 2020-09-16 Сигмойд Фарма Лимитед Композиции, содержащие циклоспорин
WO2020050182A1 (ja) * 2018-09-06 2020-03-12 株式会社カマタ カプセル充填用液状組成物及びカプセル剤
HRP20230548T1 (hr) * 2018-11-26 2023-08-04 Hepion Pharmaceuticals, Inc. Farmaceutske formulacije analoga ciklosporina

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1274354A (fr) * 1956-03-10 1961-10-27 Agents tensio-actifs obtenus à partir de triglycérides et polyéthylène glycol
DE2907460A1 (de) * 1978-03-07 1979-09-13 Sandoz Ag Neue resorbierbare galenische kompositionen
CH641356A5 (en) * 1979-02-27 1984-02-29 Sandoz Ag Pharmaceutical compositions containing cyclosporin
PH19156A (en) * 1982-02-01 1986-01-15 Sandoz Ltd Dihydrocyclosporin d in the treatment of multiple sclerosis
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
JPS62201591A (ja) * 1986-02-28 1987-09-05 Shoichi Shimizu 油脂のグリセロリシス法
JP2632010B2 (ja) * 1988-01-29 1997-07-16 三共株式会社 シクロスポリン製剤
CH679119A5 (fi) * 1988-05-13 1991-12-31 Sandoz Ag
HU201567B (en) * 1988-07-21 1990-11-28 Gyogyszerkutato Intezet Process for production of intravenous medical compositions containing cyclosphorin
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
GB8823621D0 (en) * 1988-10-07 1988-11-16 Madhok R Compositions containing cyclosporins
JPH0738771B2 (ja) * 1989-01-17 1995-05-01 花王株式会社 液状食用油組成物
GB2230440B (en) * 1989-02-09 1993-05-19 Sandoz Ltd Novel cyclosporin galenic forms
AU6785490A (en) * 1989-12-18 1991-06-20 Kraft General Foods, Inc. Low-saturate edible oils and transesterification methods for production thereof
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
DE4244930C2 (de) 1999-11-11
GB9113872D0 (en) 1991-08-14
FI922958A0 (fi) 1992-06-25
NO964382L (no) 1992-12-28
JP3420897B2 (ja) 2003-06-30
MY109512A (en) 1997-02-28
UA35559C2 (uk) 2001-04-16
IE922082A1 (en) 1992-12-30
ITRM920476A0 (it) 1992-06-23
CA2072509A1 (en) 1992-12-28
RU2143919C1 (ru) 2000-01-10
ZA924719B (en) 1993-12-27
AU659460B2 (en) 1995-05-18
DK0953630T3 (da) 2004-11-01
FI961513A0 (fi) 1996-04-03
CH685764A5 (de) 1995-09-29
CA2175842A1 (en) 1992-12-28
FI116199B (fi) 2005-10-14
CA2175842C (en) 2002-05-07
IL102310A0 (en) 1993-01-14
CN1079907A (zh) 1993-12-29
EP0539319B1 (en) 1999-12-08
EP0539319A3 (en) 1993-06-09
PH30337A (en) 1997-04-02
IE73662B1 (en) 1997-06-18
CH684163A5 (de) 1994-07-29
JPH09118894A (ja) 1997-05-06
NO922506L (no) 1992-12-28
DE4219526C2 (de) 1999-04-22
MX9203236A (es) 1992-12-01
SA92130213B1 (ar) 2004-07-24
FI109454B (fi) 2002-08-15
PT953630E (pt) 2004-11-30
CZ197792A3 (en) 1993-01-13
DE4244986B4 (de) 2008-07-24
ITRM920476A1 (it) 1993-12-23
NO303964B1 (no) 1998-10-05
SK197792A3 (en) 1994-03-09
GB9213393D0 (en) 1992-08-05
CZ281790B6 (cs) 1997-01-15
HK57196A (en) 1996-04-12
KR0131064B1 (ko) 1998-04-17
DE4219526A1 (de) 1993-03-18
JP2653958B2 (ja) 1997-09-17
GB2257359A (en) 1993-01-13
RO111021B1 (ro) 1996-06-28
RO111110B1 (ro) 1996-06-28
IT1254401B (it) 1995-09-14
FR2678169A1 (fr) 1992-12-31
SK278759B6 (sk) 1998-02-04
HU9201975D0 (en) 1992-09-28
NO922506D0 (no) 1992-06-25
JPH05186365A (ja) 1993-07-27
AU1852792A (en) 1993-03-11
FI961513L (fi) 1996-04-03
CY1906A (en) 1992-06-24
KR930000113A (ko) 1993-01-15
DK0539319T3 (da) 2000-05-22
KR100231385B1 (en) 1999-11-15
PT539319E (pt) 2000-05-31
CA2072509C (en) 1996-07-30
HU216792B (hu) 1999-08-30
FR2685706A1 (fr) 1993-07-02
HUT62201A (en) 1993-04-28
IL102310A (en) 1997-03-18
HK157696A (en) 1996-08-30
EE03108B1 (et) 1998-08-17
FR2685706B1 (fi) 1994-12-23
NZ243309A (en) 1995-02-24
LU88138A1 (fr) 1994-03-01
TW267943B (fi) 1996-01-11
CN1077798C (zh) 2002-01-16
AT403436B (de) 1998-02-25
IL118546A0 (en) 1996-10-16
NO325267B1 (no) 2008-03-17
GR3032366T3 (en) 2000-04-27
GB2257359B (en) 1996-01-10
ES2227921T3 (es) 2005-04-01
EP0953630B1 (en) 2004-09-08
ATA129892A (de) 1997-07-15
EP0539319A2 (en) 1993-04-28
UY23864A1 (es) 1995-05-29
ES2142818T3 (es) 2000-05-01
EP0953630A1 (en) 1999-11-03
FR2678169B1 (fr) 1994-08-26
KR100231384B1 (en) 1999-11-15
IL118546A (en) 1998-09-24
NO964382D0 (no) 1996-10-15

Similar Documents

Publication Publication Date Title
EE03108B1 (et) Farmatseutiline kompositsioon
FI922252L (fi) Farmaceutisk sammansaettning
FI922316L (fi) Farmaceutisk sammansaettning
FI925661L (fi) Injicerbar farmaceutisk komposition
NO923127L (no) Farmasoeytisk kombinasjonsformulering
DK0585252T3 (da) Farmaceutiske formuleringer
FI923582L (fi) Farmaceutisk sferoidkomposition
FI944832A0 (fi) Farmaseuttinen koostumus
DE4291156T1 (de) Verbesserte pharmazeutische Zusammensetzungen
BR9200058A (pt) Composto e composicao farmaceutica
FI933467L (fi) Komposition
MX9200622A (es) Composicion farmaceutica
ITMI932540A0 (it) Composizione farmaceutica
DE4294862T1 (de) Pharmazeutische Komposition
UA26064A1 (uk) Фармацевтичhа композиція
FI943705L (fi) Farmaseuttiset koostumukset
LV10579A (lv) Farmaceitiska kompozicija
FI925827L (fi) Tvaerbindbar polymerisk komposition
FI934387A0 (fi) 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner
DE69225266D1 (de) Bis-bibenzimidazol Zusammensetzung
BR9202742A (pt) Composicao delimpeza
FI940726L (fi) Farmaseuttiset koostumukset
NO924484D0 (no) Pesticid sammensetning
FI925175A0 (fi) Kompositioner haerdbara medelst straolning
FI923869L (fi) Farmaceutiska aemnen

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG

MA Patent expired